BHI (083650.KQ) — Analysis Update

Date: 2026-03-13

Current Situation

What Happened Since March 6

The ₩98,000 resistance level identified in the previous analysis was broken.

Key events:

1. Mar 9: ₩98,000 broken intraday (high ₩99,500). The level that had held as resistance on Mar 3 gave way.
2. Mar 10: Gap-up open to ₩105,800, intraday spike to ₩114,200 — a new all-time high — then closed at ₩105,000. Upper wick of ₩9,200 (8.1% intraday reversal from high). Same day, BHI announced a ₩56.6B LNG combined-cycle order.
3. Mar 11–12: Pullback from ₩105,000 to ₩99,700. Tested ₩98,400 as support (former resistance) — it held. Volume declining on the pullback.
4. Mar 13: Bounce back to ₩103,600. The ₩99,000–₩100,000 zone is acting as support.

The breakout above ₩98,000 was real, but the intraday reversal from ₩114,200 on Mar 10 created a shooting star / exhaustion candle. The stock has since consolidated between ₩99,000 and ₩107,000. This is constructive: pullback on declining volume, holding above former resistance.

2025 Financial Results (Preliminary — Announced Late Dec 2025)

BHI disclosed record 2025 results that fundamentally change the valuation picture:

Revenue nearly doubled. Operating margins expanded from 5.4% to 9.5%. The previous analysis flagged margin expansion as a key assumption for forward valuation — it has now been confirmed. The order-to-revenue conversion that was speculative in the Mar 6 analysis is now partially visible in the 2025 numbers.

Valuation (Updated With 2025 Earnings)

Forward Estimates (Kiwoom Securities, Jan 7 2026)

The valuation picture has shifted dramatically. The headline trailing P/E dropped from ~150x (on 2024 earnings) to ~53x (on 2025 earnings). On 2026 forward estimates, the stock trades at ~43x earnings. This is elevated for an industrial company but within range for a stock with 90% revenue growth and confirmed margin expansion in a nuclear + AI thematic.

What 2027-28 Could Look Like (Speculative)

If BHI continues executing at this trajectory, a sub-30x P/E by 2027 is plausible. The question is how much of 2027 is already priced in at ₩103,600.

Fundamentals

Income Statement (2024 — audited; 2025 preliminary)

The revenue jump from ₩404.7B to ₩771.6B (+91%) is driven by HRSG delivery recognition for LNG combined-cycle plants and the start of nuclear BOP revenue from Shin Hanul Units 3 & 4. HRSG represents ~73% of revenue.

Balance Sheet (2024 — Latest Audited)

Improving: Net debt declining (₩188B → ₩142B → ₩108B over 2 years). Equity nearly doubled. FCF positive.

Structural risk unchanged: ₩132.6B negative working capital. ₩125.4B in short-term debt with essentially zero long-term debt. The business relies on continuous debt rollovers. With ₩771.6B in revenue now flowing, this is less acute — but a credit disruption remains the tail risk.

Investor Flow Analysis

Cumulative Totals — Jan 2 to Mar 13 (48 trading days)

Key Shift Since Mar 6: Foreign Selling Into Strength

Since the breakout above ₩98,000, a notable divergence has emerged between institutional and foreign behavior:

Foreign investors sold 412K shares during the breakout, dropping ownership from 21.91% to 20.54%. This is a reversal from the Jan-Feb pattern where foreigners were accumulating alongside institutions.

Foreign Ownership Trajectory (Updated)

The 20% foreign ownership threshold flagged in the previous analysis as a warning level is approaching. Current 20.54% is down from the 22.61% peak on Mar 4. Net foreign selling of ~422K shares since the ATH break suggests the Jan 7 block trade holder or other foreign funds are distributing into institutional demand.

Institutional Behavior: Still Accumulating

Institutions net bought on 4 of the last 5 sessions (+378,800 shares), including the pullback days. Only today (Mar 13) was institutions net selling (-44,027). The institutional accumulation pattern that began in mid-January remains intact — they have been net buyers on 33 of 48 sessions (69%).

Broker Data (Today, Mar 13)

Foreign Estimate: Sell 44,362 | Buy 25,026 | Net -19,336

Mixed today. 신한투자증권 is the largest net buyer (+87K). NH투자증권 is the largest net seller (-69K). 키움증권 (retail-heavy) roughly balanced. No single dominant direction — consistent with the consolidation phase.

Flow Interpretation

The investor flow picture has shifted from "everyone accumulating" to "institutional accumulation absorbing foreign distribution." This is a more fragile structure than the unified buying of January-February. It suggests:

1. Foreign investors view the breakout above ₩98,000 as a distribution opportunity — taking profits after the 88% run from mid-January.
2. Institutions are the marginal buyer now, using foreign selling as a supply source.
3. As long as institutional buying exceeds foreign selling, the stock holds. But if institutions pause or slow, there is no second buyer to absorb the supply.

BHI vs KOSDAQ Comparison

Since the Mar 4 Crash

BHI has broken above its pre-crash high and made new all-time highs. KOSDAQ has not. BHI continues to diverge from the broad market.

6-Month Performance

BHI has outperformed KOSDAQ by ~80 percentage points over 6 months. This degree of divergence is stock-specific, not market-driven.

Catalysts & News Since Last Analysis

1. ₩56.6B LNG Combined-Cycle Order (Mar 10)

BHI won a ₩56.6 billion KRW order for LNG combined-cycle power plant equipment (likely HRSG units). This coincided with the ATH breakout day.

2. South Korea Accelerating Nuclear Restarts (Mar 11)

Due to the Middle East crisis disrupting LNG supply chains (Iran-related disruption to Qatar LNG), South Korea announced it will speed up nuclear reactor restarts. Two units targeted for restart in March, four more by mid-May. This increases urgency around nuclear infrastructure maintenance and equipment supply — directly relevant to BHI as a nuclear BOP vendor.

3. Korea-Turkey Nuclear Feasibility Study (Feb 25)

KEPCO and Turkey launched a preliminary feasibility study for Turkey's second nuclear power plant at Sinop. As a qualified nuclear BOP supplier to KHNP/KEPCO projects, any Korean nuclear export contract would generate equipment orders for BHI.

4. Two New Domestic Nuclear Plants Confirmed (Jan 2026)

The Lee administration confirmed construction of two new large reactors under the 11th Basic Plan. Site selection is underway; construction permits expected early 2030s. These are additional long-term order sources for BHI.

5. Czech Dukovany Nuclear Orders (Expected Q4 2026)

Per Kiwoom Securities, BHI is expected to receive auxiliary equipment orders for the Czech Dukovany nuclear project in Q4 2026. This would represent BHI's first European nuclear contract.

6. 2026 Analyst Outlook (Kiwoom, Jan 7)

• Revenue forecast: ₩952.3B (+23% YoY)
• Operating profit forecast: ₩109.5B (+49% YoY)
• New orders expected: >₩1T annually
• Nuclear + hydrogen/SMR represent growth optionality beyond the HRSG base

Technical Analysis

Key Levels

Momentum

The stock is extremely extended above both moving averages. However, the MAs are lagging indicators that reflect the stock's rapid ascent, not necessarily a reversal signal when fundamental growth justifies the move.

Price Structure

The ₩114,200 intraday high on Mar 10 followed by a pullback to ₩99,700 created a potential blow-off top candle. However:

• The pullback found support at the ₩98,000–99,000 zone (former resistance turned support)
• Volume declined on the pullback (Mar 11: 833K, Mar 12: 553K) — not distribution
• Today's bounce to ₩103,600 on 836K volume shows buyers returning

This looks more like a breakout-pullback-retest pattern than a blow-off top. As long as ₩98,000 holds as support, the technical structure is constructive for a retest of ₩114,200.

Macro Context Update

Iran/Hormuz Crisis — Ongoing

The Strait of Hormuz disruption that triggered the Mar 3-4 crash remains unresolved. Korea's energy vulnerability continues to drive policy urgency around nuclear. The Mar 11 announcement of accelerated nuclear restarts is a direct consequence.

For BHI specifically: The crisis strengthens the long-term nuclear thesis (energy security imperative) while creating short-term macro risk (Korea's economic outlook, credit conditions). The stock has so far been trading on the thesis side, not the macro risk side.

Oil Price / Energy Security

Sustained oil price elevation reinforces the nuclear-as-baseload-alternative narrative. Every week the Hormuz situation persists increases policy momentum toward nuclear buildout — which flows directly into BHI's order pipeline.

Assessment

What Changed Since March 6

The Bull Case (Stronger Than Mar 6)

1. Valuation has re-rated from speculative to high-growth. The 2025 earnings transform BHI from a 150x P/E stock relying on theoretical future earnings to a 53x trailing / 43x forward P/E stock with confirmed 91% revenue growth and margin expansion. This is expensive but defensible for a company with a multi-year order backlog.

2. ₩98,000 resistance broken. The critical technical level held for months. Breaking it puts the stock in price discovery with no overhead supply (except the ₩114,200 ATH, which was a single intraday spike).

3. Catalyst pipeline deepening. The nuclear restarts, Czech Dukovany, Turkey feasibility, new domestic reactors — these are incremental order sources that extend the growth runway. HRSG demand from LNG/data centers provides the base.

4. Institutional accumulation ongoing. +2.25M shares over 48 sessions. Still buying on pullbacks.

The Bear Case (One Key Deterioration)

1. Foreign distribution is real. Ownership declining from 22.6% to 20.5% over 2 weeks. The Jan 7 block trade holder or other foreign funds are taking profits. If this accelerates, it removes a key demand pillar. The 20% level flagged as critical in the previous analysis is approaching.

2. Mar 10 shooting star at ₩114,200. The intraday reversal from the ATH was sharp (8.1% from high to close). This is a supply signal at elevated prices. The stock needs to absorb this supply before retesting.

3. Institutions are the only buyer left. With foreign selling and retail roughly flat, institutional demand alone is supporting the stock. One-legged demand is fragile.

4. Extended technicals. +43% above 50-day MA, +98% above 200-day MA. Any pause in catalysts or institutional buying creates room for mean reversion.

5. Balance sheet fragility unchanged. ₩132.6B negative working capital with short-term debt. The revenue growth reduces this risk operationally but doesn't eliminate the structural dependency on credit markets.

Net Assessment

The fundamental picture is materially better than March 6. Revenue nearly doubling, margins expanding to 9.5%, and a confirmed order backlog convert the valuation from speculative to growth-industrial. At ~43x forward earnings with 90%+ revenue growth, the valuation is high but no longer absurd.

The flow picture is more fragile. The shift from coordinated institutional + foreign buying to institutional-only buying with foreign distribution is a downgrade in demand quality. This doesn't mean the stock collapses — institutional accumulation can sustain prices for extended periods — but it narrows the margin of safety.

The primary risk has shifted from "valuation is unjustifiable" (which 2025 earnings addressed) to "who buys if institutions stop?"

Summary

BHI at ₩103,600 is a fundamentally different stock than the ₩94,800 analyzed on March 6. The difference isn't the 9% price move — it's the 2025 earnings. Revenue of ₩771.6B (+91%), operating profit of ₩73.3B (+233%), and an order backlog of ₩1.8T convert this from a speculative momentum trade into a high-growth industrial with confirmed execution.

The trailing P/E dropped from ~150x (on 2024 earnings) to ~53x (on 2025 earnings). On 2026 analyst estimates, it trades at ~43x forward. This is expensive but not irrational for a company growing revenue 90% with expanding margins in a nuclear + AI power demand thematic.

The key deterioration is in demand structure. Foreign investors are distributing into the breakout (ownership 22.6% → 20.5%), leaving institutions as the sole structural buyer. This is sustainable for weeks or months — institutional accumulation programs don't stop on a dime — but it narrows the base of support.

The three things to watch:

1. Foreign ownership % (currently 20.54%). A drop below 20% confirms distribution. Below 18% is a sell signal.
2. ₩98,000 as support. Former resistance, now support. If it holds on pullbacks, the breakout structure is intact. If it breaks, the Jan-Feb accumulation pattern may unwind.
3. Institutional net flow. Positive on 33 of 48 sessions. A shift to net negative for 3+ sessions would be the leading indicator of demand exhaustion.

The stock's trajectory depends on whether institutional demand can sustain until 2026 earnings arrive (projected ₩109.5B operating profit, ₩952B revenue) to justify the price. If the next two quarters deliver, the current price will look reasonable in hindsight. If they don't, the stock is 43% above its 50-day MA with a single-buyer demand structure.